Vanguard Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.9M | Sell |
|
|||||
|
2025
Q1 | $8.37M | Sell |
|
|||||
|
2024
Q4 | $11.5M | Sell |
|
|||||
|
2024
Q3 | $17.1M | Buy |
|
|||||
|
2024
Q2 | $16.1M | Buy |
|
|||||
|
2024
Q1 | $11.3M | Buy |
|
|||||
|
2023
Q4 | $6.8M | Sell |
|
|||||
|
2023
Q3 | $7.18M | Buy |
|
|||||
|
2023
Q2 | $6.93M | Sell |
|
|||||
|
2023
Q1 | $13.9M | Sell |
|
|||||
|
2022
Q4 | $52.1M | Sell |
|
|||||
|
2022
Q3 | $74.1M | Buy |
|
|||||
|
2022
Q2 | $78.3M | Buy |
|
|||||
|
2022
Q1 | $105M | Buy |
|
|||||
|
2021
Q4 | $250M | Buy |
|
|||||
|
2021
Q3 | $307M | Buy |
|
|||||
|
2021
Q2 | $292M | Buy |
|
|||||
|
2021
Q1 | $334M | Buy |
|
|||||
|
2020
Q4 | $277M | Buy |
|
|||||
|
2020
Q3 | $263M | Sell |
|
|||||
|
2020
Q2 | $382M | Sell |
|
|||||
|
2020
Q1 | $295M | Buy |
|
|||||
|
2019
Q4 | $349M | Sell |
|
|||||
|
2019
Q3 | $325M | Sell |
|
|||||
|
2019
Q2 | $659M | Buy |
|
|||||
|
2019
Q1 | $610M | Sell |
|
|||||
|
2018
Q4 | $602M | Sell |
|
|||||
|
2018
Q3 | $1.15B | Buy |
|
|||||
|
2018
Q2 | $892M | Buy |
|
|||||
|
2018
Q1 | $1.83B | Buy |
|
|||||
|
2017
Q4 | $885M | Buy |
|
|||||
|
2017
Q3 | $343M | Buy |
|
|||||
|
2017
Q2 | $274M | Buy |
|
|||||
|
2017
Q1 | $319M | Buy |
|
|||||
|
2016
Q4 | $159M | Buy |
|
|||||
|
2016
Q3 | $199M | Sell |
|
|||||
|
2016
Q2 | $166M | Buy |
|
|||||
|
2016
Q1 | $156M | Buy |
|
|||||
|
2015
Q4 | $176M | Buy |
|
|||||
|
2015
Q3 | $112M | Buy |
|
|||||
|
2015
Q2 | $124M | Buy |
|
|||||
|
2015
Q1 | $96.2M | Buy |
|
|||||
|
2014
Q4 | $129M | Buy |
|
|||||
|
2014
Q3 | $98M | Buy |
|
|||||
|
2014
Q2 | $104M | Sell |
|
|||||
|
2014
Q1 | $98.7M | Buy |
|
|||||
|
2013
Q4 | $85.4M | Buy |
|
|||||
|
2013
Q3 | $73.6M | Buy |
|
|||||
|
2013
Q2 | $78.8M | Buy |
|